MV Management XI, L.L.C.
CIK
1503556
Location
MENLO PARK, CA
Portfolio Value
Micro
$6,034,029
Diversification
Highly concentrated
Filing Date
Global Rank
#6,646
/ 6,900
▼ 258
· as of Sep 2023
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-40.1%
Period ended 2 years ago
Filed Nov 14, 2023 · 2y
8 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-45.8%
SPY
+76.0%
Annualised alpha
-39.2%
Max drawdown
−82.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
1 positions · as of Sep 30, 2023 · Δ vs Jun 30, 2023Top Position
100.0%
0.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated0
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2023| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $6,034,029 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals, Inc. | −1,183,146 | 788,762 | $6,034,029 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
1 positions ·
$6,034,029 total
· as of Sep 30, 2023
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RXRX |
Recursion Pharmaceuticals, Inc.
Healthcare
|
Reduced | 788,762 | $6,034,029 | 100.00% |